Recommendations from the EGAPP Working Group: Can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

Ned Calonge, Nancy L. Fisher, Alfred O. Berg, Doug Campos-Outcalt, Benjamin Djulbegovic, Theodore G. Ganiats, James E. Haddow, Roger D. Klein, Donald O. Lyman, Kenneth Offit, Stephen G. Pauker, Margaret Piper, Carolyn Sue Richards, Ora L. Strickland, Sean R. Tunis, David L. Veenstra

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Recommendations from the EGAPP Working Group: Can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences